- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
强势上涨过程中，可逢低买进，暂不考虑做空。
- 中期趋势：
上涨趋势有所减缓，可适量高抛低吸。
- 长期趋势：
已有23家主力机构披露2025-06-30报告期持股数据，持仓量总计2654.65万股，占流通A股2.74%
- 波段诊断：
-
技术面诊股
诊断结果：6.9技术面打败了66%的股票
技术面评分前10的股票
近期的平均成本为4.43元。多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
平均成本
近期的平均成本为4.43元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"4.43","date":1761466469,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2025.10.27","stock":"0.45","trade":"0.79","ind":"1.51"},{"date":"2025.10.24","stock":"-0.45","trade":"-0.38","ind":"2.02"},{"date":"2025.10.23","stock":"-0.22","trade":"-1.12","ind":"0.22"},{"date":"2025.10.22","stock":"0.45","trade":"0.67","ind":"-0.62"},{"date":"2025.10.21","stock":"1.84","trade":"1.33","ind":"2.06"},{"date":"2025.10.20","stock":"0.69","trade":"0.37","ind":"0.98"},{"date":"2025.10.17","stock":"-2.04","trade":"-1.01","ind":"-3.04"},{"date":"2025.10.16","stock":"-0.23","trade":"0.19","ind":"-0.25"},{"date":"2025.10.15","stock":"1.38","trade":"2.81","ind":"1.73"},{"date":"2025.10.14","stock":"0.00","trade":"-1.22","ind":"-2.54"},{"date":"2025.10.13","stock":"-0.68","trade":"-0.84","ind":"-0.93"},{"date":"2025.10.10","stock":"0.46","trade":"-0.24","ind":"-2.70"},{"date":"2025.10.09","stock":"0.23","trade":"-0.39","ind":"1.47"},{"date":"2025.09.30","stock":"1.16","trade":"0.72","ind":"0.35"},{"date":"2025.09.29","stock":"0.47","trade":"-0.14","ind":"2.05"},{"date":"2025.09.26","stock":"0.00","trade":"-1.67","ind":"-1.76"},{"date":"2025.09.25","stock":"-1.38","trade":"-0.91","ind":"0.67"},{"date":"2025.09.24","stock":"0.92","trade":"1.94","ind":"1.80"},{"date":"2025.09.23","stock":"-2.26","trade":"-1.95","ind":"-0.29"},{"date":"2025.09.22","stock":"0.23","trade":"-0.40","ind":"0.67"},{"date":"2025.09.19","stock":"-2.64","trade":"-1.50","ind":"-0.04"}]
福安药业,深证成指,化学制药指数
压力支撑
该股压力位为4.42元，支撑位为4.40元。
[{"text":"\u538b\u529b\u4f4d","value":"4.42","date":1761494400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"4.40","date":1761494400,"color":"0x0b52a1"}]
多空趋势
多头行情中，上涨趋势有所减缓，可适量做高抛低吸。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.2资金面打败了31%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月27日 20:30
| 机构今日流向(万元) | 485.98 | 机构5日流向(万元) | -5163.11 |
| 机构10日流向(万元) | -9773.74 | 机构20日流向(万元) | -19499.34 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量减少1168.22万股，其中基金净减仓8家，主力净减仓28家，请投资者中长期谨慎为宜。
截止2025-06-30，共23家主力机构（基金20家，一般法人3家），持仓量总计2654.65万股，占流通A股2.74%
其中，基金持仓与2024-12-31相比：
增仓：1家 ，增持 0.36万股
减仓：9家 ，减持 86.85万股
新出现在主力名单中：9家 ，持有553.39万股
从主力名单中消失：37家 ，原持有1022.35万股
其中，基金持仓与2024-12-31相比：
增仓：1家 ，增持 0.36万股
减仓：9家 ，减持 86.85万股
新出现在主力名单中：9家 ，持有553.39万股
从主力名单中消失：37家 ，原持有1022.35万股
消息面诊股
诊断结果：5.5消息面打败了28%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 福安药业前三季度营业收入13.15亿元，同比下降3
2025-10-27 - 福安药业（截止2025年10月20日）股东人数为3
2025-10-27 - 福安药业：10月24日获融资买入1390.95万元
2025-10-27 - 福安药业：10月23日获融资买入1002.80万元
2025-10-24 - 福安药业：10月22日获融资买入914.33万元
2025-10-23 - 福安药业：10月21日获融资买入1237.37万元
2025-10-22 - 毒株与去年不同 流感季或提前！防护要趁早
2025-10-21 - 福安药业：10月20日获融资买入621.52万元
2025-10-21 - 福安药业：10月17日获融资买入1579.71万元
2025-10-20 - 福安药业：10月16日获融资买入834.24万元
2025-10-17
消息列表
| 一般消息 | 高管变动 | 取消监事会 | 2025-09-15 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-27 |
| 利好 | 分红转增 | 10派0.20元(含税) | 2025-08-27 |
| 重大利空 | 业绩预告 | 业绩大幅下降 | 2025-07-18 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 利好 | 分红转增 | 10派0.5元(含税) | 2025-04-24 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2024-12-31 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2024-11-05 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 4条 | 0条 | 4条 |
| 利空 | 2条 | 1条 | 1条 |
行业面诊股
诊断结果：6.8行业面打败了91%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，接近大盘。
[{"date":"2025.10.27","price":"1.51","value":"0.79"},{"date":"2025.10.24","price":"2.02","value":"-0.38"},{"date":"2025.10.23","price":"0.22","value":"-1.12"},{"date":"2025.10.22","price":"-0.62","value":"0.67"},{"date":"2025.10.21","price":"2.06","value":"1.33"},{"date":"2025.10.20","price":"0.98","value":"0.37"},{"date":"2025.10.17","price":"-3.04","value":"-1.01"},{"date":"2025.10.16","price":"-0.25","value":"0.19"},{"date":"2025.10.15","price":"1.73","value":"2.81"},{"date":"2025.10.14","price":"-2.54","value":"-1.22"},{"date":"2025.10.13","price":"-0.93","value":"-0.84"},{"date":"2025.10.10","price":"-2.70","value":"-0.24"},{"date":"2025.10.09","price":"1.47","value":"-0.39"},{"date":"2025.09.30","price":"0.35","value":"0.72"},{"date":"2025.09.29","price":"2.05","value":"-0.14"},{"date":"2025.09.26","price":"-1.76","value":"-1.67"},{"date":"2025.09.25","price":"0.67","value":"-0.91"},{"date":"2025.09.24","price":"1.80","value":"1.94"},{"date":"2025.09.23","price":"-0.29","value":"-1.95"},{"date":"2025.09.22","price":"0.67","value":"-0.40"},{"date":"2025.09.19","price":"-0.04","value":"-1.50"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 能特科技 | 233.33% | -0.76% | 6.4分 |
| 2 | 向日葵 | 90.12% | 11.33% | 5.3分 |
| 3 | *ST景峰 | 31.23% | 22.45% | 5.1分 |
| 4 | 常山药业 | 29.43% | 13.95% | 6.2分 |
| 5 | 多瑞医药 | 28.25% | 7.94% | 6.1分 |
| 6 | 宏源药业 | 17.02% | -0.59% | 4.1分 |
| 8 | 兴齐眼药 | 14.74% | 4.67% | 6.8分 |
| 10 | 纳微科技 | 12.50% | 9.20% | 6.2分 |
| 12 | *ST苏吴 | 9.78% | 4.12% | 4.6分 |
| 14 | 辰欣药业 | 7.73% | -0.54% | 5.8分 |
| 16 | 信立泰 | 7.01% | 0.57% | 6.2分 |
| 18 | 圣诺生物 | 6.41% | 5.21% | 6.7分 |
| 20 | 西点药业 | 5.88% | 4.29% | 6.0分 |
| 22 | 山河药辅 | 5.24% | 3.51% | 5.3分 |
| 24 | 富士莱 | 5.17% | 1.15% | 5.4分 |
| 26 | 莱美药业 | 4.98% | 0.43% | 6.1分 |
| 28 | *ST三圣 | 4.20% | 3.33% | 4.6分 |
| 30 | 中关村 | 4.09% | 1.13% | 5.7分 |
| 32 | 双鹭药业 | 3.58% | 2.17% | 5.9分 |
| 34 | 仟源医药 | 3.20% | 0.18% | 6.1分 |
| 36 | 东北制药 | 2.91% | 0.35% | 6.3分 |
| 38 | 联环药业 | 2.69% | 1.38% | 5.8分 |
| 40 | 鲁抗医药 | 2.32% | 0.89% | 6.0分 |
| 42 | 华北制药 | 2.20% | 2.37% | 6.1分 |
| 44 | 汉商集团 | 2.08% | 1.14% | 6.3分 |
| 46 | 康芝药业 | 1.62% | -12.10% | 4.9分 |
| 48 | 津药药业 | 1.44% | 1.69% | 6.0分 |
| 50 | 立方制药 | 0.91% | 1.02% | 5.6分 |
| 52 | 昂利康 | 0.81% | -4.75% | 5.3分 |
| 54 | 华仁药业 | 0.60% | 2.13% | 5.9分 |
| 56 | - | 0.42% | 3.71% | 分 |
| 58 | 拓新药业 | 0.16% | 0.00% | 4.8分 |
| 60 | 溢多利 | 0.00% | 1.46% | 5.0分 |
| 62 | 海正药业 | -0.19% | 0.48% | 6.1分 |
| 64 | 海森药业 | -0.37% | 0.17% | 5.3分 |
| 66 | 国药现代 | -0.55% | 1.12% | 5.7分 |
| 68 | 浙江医药 | -0.69% | 1.98% | 5.7分 |
| 70 | 奥锐特 | -1.06% | 2.23% | 5.8分 |
| 72 | 复旦张江 | -1.71% | 2.46% | 5.8分 |
| 74 | 新天地 | -2.01% | -0.45% | 5.3分 |
| 76 | 永安药业 | -2.13% | -2.08% | 3.6分 |
| 78 | 新和成 | -2.33% | 0.73% | 5.6分 |
| 80 | 新华制药 | -2.51% | -1.73% | 5.6分 |
| 82 | 易明医药 | -2.67% | 6.15% | 5.7分 |
| 84 | 润都股份 | -2.83% | 0.69% | 5.3分 |
| 86 | - | -3.13% | 3.95% | 分 |
| 88 | 海南海药 | -3.23% | -2.40% | 5.7分 |
| 90 | 花园生物 | -3.39% | 1.56% | 4.8分 |
| 92 | - | -3.61% | 4.26% | 分 |
| 94 | 恒瑞医药 | -3.79% | 2.89% | 6.1分 |
| 96 | 舒泰神 | -3.86% | -12.87% | 5.1分 |
| 98 | - | -3.91% | 4.43% | 分 |
| 100 | 华东医药 | -4.13% | -0.65% | 5.6分 |
| 102 | 科伦药业 | -4.35% | -4.49% | 5.4分 |
| 104 | 前沿生物 | -4.50% | 0.14% | 4.8分 |
| 106 | 福元医药 | -4.68% | -4.01% | 5.6分 |
| 108 | 海创药业 | -5.02% | 3.79% | 5.5分 |
| 110 | - | -5.21% | 6.06% | 分 |
| 112 | 普洛药业 | -5.46% | -2.38% | 5.5分 |
| 114 | 百利天恒 | -5.58% | 1.09% | 5.1分 |
| 116 | 尔康制药 | -5.75% | 0.29% | 5.4分 |
| 118 | 健康元 | -6.15% | -1.33% | 4.7分 |
| 120 | 小方制药 | -6.24% | 0.99% | 5.9分 |
| 122 | 海辰药业 | -6.47% | 0.00% | 4.7分 |
| 124 | 千红制药 | -6.71% | -4.09% | 4.9分 |
| 126 | 富祥药业 | -7.08% | -3.63% | 4.8分 |
| 128 | 丽珠集团 | -7.46% | -2.44% | 4.8分 |
| 130 | 键凯科技 | -8.24% | 3.01% | 5.9分 |
| 132 | 微芯生物 | -8.50% | -1.11% | 5.3分 |
| 134 | 恩华药业 | -9.29% | -2.92% | 4.6分 |
| 136 | 翰宇药业 | -9.73% | 2.59% | 6.0分 |
| 138 | 吉贝尔 | -10.43% | 1.25% | 5.7分 |
| 140 | 京新药业 | -10.60% | -2.05% | 4.8分 |
| 142 | - | -11.27% | 3.21% | 分 |
| 144 | 奥赛康 | -11.45% | -2.85% | 5.5分 |
| 146 | 迪哲医药 | -12.22% | -2.17% | 5.4分 |
| 148 | 金城医药 | -14.32% | 3.35% | 5.4分 |
| 150 | 华纳药厂 | -16.16% | -4.36% | 5.1分 |
| 152 | 泰恩康 | -17.44% | -0.46% | 4.1分 |
| 154 | ST复华 | -26.37% | -0.56% | 5.3分 |
| 156 | 南新制药 | -30.23% | 3.89% | 5.4分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-06-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 76/219 ， 100/219。
[{"date":"2025-06-30","value":"2.56","vol":"1.21"},{"date":"2025-03-31","value":"1.56","vol":"-0.17"},{"date":"2024-12-31","value":"6.55","vol":"19.51"},{"date":"2024-09-30","value":"7.06","vol":"4.58"},{"date":"2024-06-30","value":"5.12","vol":"3.52"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
2.56 | 1.56 | 6.55 | 7.06 | 5.12 |
| 行业(%) | 1.21 | -0.17 | 19.51 | 4.58 | 3.52 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"37.14","vol":"49.43"},{"date":"2025-03-31","value":"40.74","vol":"49.23"},{"date":"2024-12-31","value":"52.96","vol":"50.77"},{"date":"2024-09-30","value":"52.96","vol":"50.17"},{"date":"2024-06-30","value":"53.37","vol":"50.51"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
37.14 | 40.74 | 52.96 | 52.96 | 53.37 |
| 行业(%) | 49.43 | 49.23 | 50.77 | 50.17 | 50.51 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 141/219 ， 114/219。
[{"date":"2025-06-30","value":"-35.76","vol":"78.53"},{"date":"2025-03-31","value":"-42.22","vol":"-0.84"},{"date":"2024-12-31","value":"-9.68","vol":"17.76"},{"date":"2024-09-30","value":"0.62","vol":"45.39"},{"date":"2024-06-30","value":"7.87","vol":"705.61"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-35.76 | -42.22 | -9.68 | 0.62 | 7.87 |
| 行业(%) | 78.53 | -0.84 | 17.76 | 45.39 | 705.61 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"-47.74","vol":"56.29"},{"date":"2025-03-31","value":"-43.63","vol":"-21.21"},{"date":"2024-12-31","value":"20.69","vol":"-20.55"},{"date":"2024-09-30","value":"19.76","vol":"-32.11"},{"date":"2024-06-30","value":"34.55","vol":"8.09"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-47.74 | -43.63 | 20.69 | 19.76 | 34.55 |
| 行业(%) | 56.29 | -21.21 | -20.55 | -32.11 | 8.09 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 98/219 ， 109/219。
[{"date":"2025-06-30","value":"0.15","vol":"0.21"},{"date":"2025-03-31","value":"0.08","vol":"0.10"},{"date":"2024-12-31","value":"0.40","vol":"0.43"},{"date":"2024-09-30","value":"0.33","vol":"0.33"},{"date":"2024-06-30","value":"0.24","vol":"0.23"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.15 | 0.08 | 0.40 | 0.33 | 0.24 |
| 行业(次) | 0.21 | 0.10 | 0.43 | 0.33 | 0.23 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.73","vol":"1.31"},{"date":"2025-03-31","value":"0.34","vol":"0.67"},{"date":"2024-12-31","value":"1.44","vol":"3.22"},{"date":"2024-09-30","value":"1.26","vol":"2.17"},{"date":"2024-06-30","value":"0.90","vol":"1.50"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.73 | 0.34 | 1.44 | 1.26 | 0.90 |
| 行业(次) | 1.31 | 0.67 | 3.22 | 2.17 | 1.50 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 99/219 ， 61/219。
[{"date":"2025-06-30","value":"7.61","vol":"2.81"},{"date":"2025-03-31","value":"5.71","vol":"-28.76"},{"date":"2024-12-31","value":"0.69","vol":"-368.97"},{"date":"2024-09-30","value":"9.51","vol":"-9.81"},{"date":"2024-06-30","value":"14.88","vol":"-253.98"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 7.61 | 5.71 | 0.69 | 9.51 | 14.88 |
| 行业 | 2.81 | -28.76 | -368.97 | -9.81 | -253.98 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.70","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.21","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.19","vol":"2.17"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.70 | - | 1.21 | - | 1.19 |
| 行业 | 1.72 | 0.00 | 1.99 | 0.00 | 2.17 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 6/219 ， 20/219。
[{"date":"2025-06-30","value":"1.91","vol":"3.67"},{"date":"2025-03-31","value":"2.01","vol":"3.59"},{"date":"2024-12-31","value":"1.68","vol":"3.34"},{"date":"2024-09-30","value":"1.66","vol":"3.63"},{"date":"2024-06-30","value":"1.59","vol":"3.56"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.91 | 2.01 | 1.68 | 1.66 | 1.59 |
| 行业 | 3.67 | 3.59 | 3.34 | 3.63 | 3.56 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"1.18","vol":"2.89"},{"date":"2025-03-31","value":"1.21","vol":"2.81"},{"date":"2024-12-31","value":"0.94","vol":"2.64"},{"date":"2024-09-30","value":"1.02","vol":"2.90"},{"date":"2024-06-30","value":"0.99","vol":"2.86"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.18 | 1.21 | 0.94 | 1.02 | 0.99 |
| 行业 | 2.89 | 2.81 | 2.64 | 2.90 | 2.86 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 84/219 ， 88/219。
[{"date":"2025-06-30","value":"25.94","vol":"33.79"},{"date":"2025-03-31","value":"26.84","vol":"34.04"},{"date":"2024-12-31","value":"26.44","vol":"34.19"},{"date":"2024-09-30","value":"27.09","vol":"32.80"},{"date":"2024-06-30","value":"27.94","vol":"32.96"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
25.94 | 26.84 | 26.44 | 27.09 | 27.94 |
| 行业(%) | 33.79 | 34.04 | 34.19 | 32.80 | 32.96 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-06-30","value":"0.35","vol":"0.88"},{"date":"2025-03-31","value":"0.37","vol":"1.46"},{"date":"2024-12-31","value":"0.36","vol":"0.84"},{"date":"2024-09-30","value":"0.37","vol":"0.72"},{"date":"2024-06-30","value":"0.39","vol":"0.70"}]
| 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.35 | 0.37 | 0.36 | 0.37 | 0.39 |
| 行业(%) | 0.88 | 1.46 | 0.84 | 0.72 | 0.70 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"-2.97","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"2.05","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"2.32","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"2.80","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.59","blueLineValue":"0.13","type":"YC"}]